{"altmetric_id":910934,"counts":{"readers":{"mendeley":29,"citeulike":0,"connotea":0},"facebook":{"unique_users_count":3,"unique_users":["173273506047993","149924961793990","200610623392044"],"posts_count":3},"blogs":{"unique_users_count":1,"unique_users":[51846],"posts_count":1},"linkedin":{"unique_users_count":1,"unique_users":["private"],"posts_count":1},"news":{"unique_users_count":2,"unique_users":["popular_science","la_repubblica"],"posts_count":2},"total":{"posts_count":16},"twitter":{"unique_users_count":9,"unique_users":["PatrickLacasse","Enrique2604","Nanomedicina","NicholasMMurphy","DignitasIntl","PLOSGenetics","johnapple","janinemccready","AntonTankovich"],"posts_count":9}},"selected_quotes":["#AIDS Virus Could Be Harnessed to Fight #Cancer - Full research","In Francia si prova ad usare #hiv modificato per combattere il #cancro","Seg\u00fan el CNRS el HIV puede ser empleado para combatir el c\u00e1ncer (retrovoluci\u00f3n). En"],"citation":{"abstract":"In evolution strategies aimed at isolating molecules with new functions, screening for the desired phenotype is generally performed in vitro or in bacteria. When the final goal of the strategy is the modification of the human cell, the mutants selected with these preliminary screenings may fail to confer the desired phenotype, due to the complex networks that regulate gene expression in higher eukaryotes. We developed a system where, by mimicking successive infection cycles with HIV-1 derived vectors containing the gene target of the evolution in their genome, libraries of gene mutants are generated in the human cell, where they can be directly screened. As a proof of concept we created a library of mutants of the human deoxycytidine kinase (dCK) gene, involved in the activation of nucleoside analogues used in cancer treatment, with the aim of isolating a variant sensitizing cancer cells to the chemotherapy compound Gemcitabine, to be used in gene therapy for anti-cancer approaches or as a poorly immunogenic negative selection marker for cell transplantation approaches. We describe the isolation of a dCK mutant, G12, inducing a 300-fold sensitization to Gemcitabine in cells originally resistant to the prodrug (Messa 10K), an effect 60 times stronger than the one induced by the wt enzyme. The phenotype is observed in different tumour cell lines irrespective of the insertion site of the transgene and is due to a change in specificity of the mutated kinase in favour of the nucleoside analogue. The mutations characterizing G12 are distant from the active site of the enzyme and are unpredictable on a rational basis, fully validating the pragmatic approach followed. Besides the potential interest of the G12 dCK variant for therapeutic purposes, the methodology developed is of interest for a large panel of applications in biotechnology and basic research.","abstract_source":"pubmed","altmetric_jid":"4f6fa5123cf058f61000334a","authors":["Paola Rossolillo","Flore Winter","Etienne Simon-Loriere","Sarah Gallois-Montbrun","Matteo Negroni"],"doi":"10.1371\/journal.pgen.1002904","first_seen_on":"2012-08-24T16:11:06+00:00","issns":["1553-7404"],"issue":"8","journal":"PLoS Genetics","last_mentioned_on":1348225110,"links":["http:\/\/feeds.plos.org\/~r\/plosgenetics\/NewArticles\/~3\/w9nhvEQlUp0\/info:doi\/10.1371\/journal.pgen.1002904"],"pdf_url":"http:\/\/dx.plos.org\/10.1371\/journal.pgen.1002904.pdf","pmid":"22927829","pubdate":"2012-08-23T00:00:00+00:00","publisher":"Public Library of Science","publisher_subjects":[{"name":"Genetics","scheme":"era"}],"scopus_subjects":["Life Sciences","Medicine","Health Sciences","Agricultural and Biological Sciences","Biochemistry, Genetics and Molecular Biology"],"startpage":"e1002904","subjects":["genetics"],"title":"Retrovolution: HIV\u2013Driven Evolution of Cellular Genes and Improvement of Anticancer Drug Activation","type":"article","volume":"8","mendeley_url":"http:\/\/www.mendeley.com\/research\/retrovolution-hivdriven-evolution-cellular-genes-improvement-anticancer-drug-activation"},"altmetric_score":{"score":34.396,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":34.396},"context_for_score":{"all":{"total_number_of_other_articles":7307838,"mean":6.3708105552946,"rank":207500,"this_scored_higher_than_pct":97,"this_scored_higher_than":7100320,"rank_type":"exact","sample_size":7307838,"percentile":97},"similar_age_3m":{"total_number_of_other_articles":96124,"mean":5.672928060922,"rank":2361,"this_scored_higher_than_pct":97,"this_scored_higher_than":93763,"rank_type":"exact","sample_size":96124,"percentile":97},"this_journal":{"total_number_of_other_articles":5016,"mean":11.500748953141,"rank":360,"this_scored_higher_than_pct":92,"this_scored_higher_than":4656,"rank_type":"exact","sample_size":5016,"percentile":92},"similar_age_this_journal_3m":{"total_number_of_other_articles":169,"mean":7.69475,"rank":5,"this_scored_higher_than_pct":97,"this_scored_higher_than":164,"rank_type":"exact","sample_size":169,"percentile":97}}},"demographics":{"poster_types":{"member_of_the_public":8,"science_communicator":1},"users":{"twitter":{"cohorts":{"Members of the public":8,"Science communicators (journalists, bloggers, editors)":1}},"mendeley":{"by_status":{"Professor > Associate Professor":1,"Researcher":11,"Student  > Doctoral Student":1,"Student  > Ph. D. Student":1,"Student  > Master":4,"Other":1,"Student  > Bachelor":8,"Lecturer":1,"Professor":1},"by_discipline":{"Medicine and Dentistry":2,"Chemistry":2,"Agricultural and Biological Sciences":22,"Business, Management and Accounting":1,"Biochemistry, Genetics and Molecular Biology":1,"Environmental Science":1}}},"geo":{"twitter":{"CA":3,"GB":1,"IT":1},"mendeley":{"US":1,"SD":1,"FR":2,"PT":1,"DE":1}}},"posts":{"facebook":[{"title":"Retrovolution: HIV\u2013Driven Evolution of Cellular Genes and Improvement of Anticancer Drug Activation","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=434715913237083&id=173273506047993","citation_ids":[910934],"posted_on":"2012-08-23T21:58:40+00:00","summary":"by Paola Rossolillo, Flore Winter, Etienne Simon-Loriere, Sarah Gallois-Montbrun, Matteo Negroni\n\n        In evolution strategies aimed at isolating molecules with new functions, screening for the desired phenotype is generally performed in vitro or in bac","author":{"name":"Open Access","url":"https:\/\/www.facebook.com\/173273506047993","facebook_wall_name":"Open Access","image":"https:\/\/graph.facebook.com\/173273506047993\/picture","id_on_source":"173273506047993"}},{"title":"http:\/\/dx.plos.org\/10.1371\/journal.pgen.1002904","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=157060537751609&id=149924961793990","citation_ids":[910934],"posted_on":"2012-08-28T15:11:55+00:00","author":{"name":"Fab\u00edola Pinheiro","url":"https:\/\/www.facebook.com\/149924961793990","facebook_wall_name":"Laborat\u00f3rio de Nanomedicina e Nanotoxicologia","image":"https:\/\/graph.facebook.com\/149924961793990\/picture","id_on_source":"149924961793990"}},{"title":"PLoS Genetics: Retrovolution: HIV\u2013Driven Evolution of Cellular Genes and Improvement of Anticancer D","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=336174116473569&id=200610623392044","citation_ids":[910934],"posted_on":"2012-08-28T13:39:59+00:00","summary":"Qual seria a aceita\u00e7\u00e3o de uma vacina contra o cancer que usa o virus HIV como ve\u00edculo?","author":{"name":"Virologia Hoje","url":"https:\/\/www.facebook.com\/200610623392044","facebook_wall_name":"Virologia Hoje","image":"https:\/\/graph.facebook.com\/200610623392044\/picture","id_on_source":"200610623392044"}}],"twitter":[{"url":"http:\/\/twitter.com\/#!\/PatrickLacasse\/status\/239248945577074688","rt":["PLOSGenetics"],"citation_ids":[910934],"posted_on":"2012-08-25T06:32:48+00:00","author":{"name":"Patrick Lacasse","image":"http:\/\/a0.twimg.com\/profile_images\/378800000085320001\/b9c19d9512360b3911707d62bc58f399_normal.jpeg","id_on_source":"PatrickLacasse","tweeter_id":"39542394","geo":{"lt":45.512303,"ln":-73.554431,"country":"CA"},"followers":83},"tweet_id":"239248945577074688"},{"url":"http:\/\/twitter.com\/#!\/Enrique2604\/status\/240434903559327744","rt":["ScienceDaily"],"citation_ids":[910934],"posted_on":"2012-08-28T13:05:22+00:00","author":{"name":"Dr. E.Zamorano-Ponce","url":"http:\/\/www.researchgate.net\/profile\/Enrique_Zamorano-Ponce\/publications\/?ev=prf_pubs_p1","image":"https:\/\/pbs.twimg.com\/profile_images\/378800000105963524\/a66ec0b10542d2fee40c2250535f5758_normal.jpeg","description":"Ph.D.","id_on_source":"Enrique2604","tweeter_id":"123452418","geo":{"lt":null,"ln":null},"followers":1047},"tweet_id":"240434903559327744"},{"url":"http:\/\/twitter.com\/#!\/Nanomedicina\/status\/240466841611423744","license":"public","citation_ids":[910934],"posted_on":"2012-08-28T15:12:17+00:00","author":{"name":"Prof. Zucolotto","url":"http:\/\/www.nanomedicina.com.br","image":"https:\/\/pbs.twimg.com\/profile_images\/1079679446\/logofinal_normal.jpg","description":"Nanomedicine laboratory. Nanotechnology. Laborat\u00f3rio de nanomedicina. Nanotecnologia","id_on_source":"Nanomedicina","tweeter_id":"164879217","followers":711},"tweet_id":"240466841611423744"},{"url":"http:\/\/twitter.com\/#!\/NicholasMMurphy\/status\/240933732335370241","citation_ids":[910934],"posted_on":"2012-08-29T22:07:32+00:00","author":{"name":"Nick Murphy","image":"https:\/\/pbs.twimg.com\/profile_images\/978677061\/345_n_normal.jpg","id_on_source":"NicholasMMurphy","tweeter_id":"74478819","geo":{"lt":null,"ln":null},"followers":814},"tweet_id":"240933732335370241"},{"url":"http:\/\/twitter.com\/#!\/DignitasIntl\/status\/247770599777251328","citation_ids":[910934],"posted_on":"2012-09-17T18:54:49+00:00","author":{"name":"Dignitas Intl","url":"http:\/\/DignitasInternational.org","image":"https:\/\/pbs.twimg.com\/profile_images\/704899156230463488\/T-zbUvic_normal.jpg","description":"We innovate solutions to health challenges, build resilient health systems, and advance the right to health for marginalized people. https:\/\/t.co\/XnBiygt6OC","id_on_source":"DignitasIntl","tweeter_id":"34666688","geo":{"lt":null,"ln":null},"followers":4550},"tweet_id":"247770599777251328"},{"url":"http:\/\/twitter.com\/#!\/PLOSGenetics\/status\/239069770140512256","citation_ids":[910934],"posted_on":"2012-08-24T18:40:49+00:00","author":{"name":"PLOS Genetics","url":"http:\/\/www.plosgenetics.org","image":"https:\/\/pbs.twimg.com\/profile_images\/2435441933\/pk712n4blw8kyf7yzqwc_normal.jpeg","description":"A peer-reviewed, open-access journal. Tweets by the editorial staff. Header Image Credit: Reed Bowman http:\/\/plos.io\/2wX2JDp","id_on_source":"PLOSGenetics","tweeter_id":"388345704","geo":{"lt":52.2,"ln":0.11667,"country":"GB"},"followers":19474},"tweet_id":"239069770140512256"},{"url":"http:\/\/twitter.com\/#!\/johnapple\/status\/249100285744672769","citation_ids":[910934],"posted_on":"2012-09-21T10:58:30+00:00","author":{"name":"Giovanni Corbisiero","url":"http:\/\/www.giovannicorbisiero.it\/","image":"https:\/\/pbs.twimg.com\/profile_images\/819954102528524289\/WztTU2bE_normal.jpg","description":"Appassionato di #medicina, #politica e #musica. Socio di AC. Chitarrista stonato. Tifoso del #Napoli. Segretario #PdMariglianella.","id_on_source":"johnapple","tweeter_id":"11600382","geo":{"lt":40.92951,"ln":14.43583,"country":"IT"},"followers":375},"tweet_id":"249100285744672769"},{"url":"http:\/\/twitter.com\/#!\/janinemccready\/status\/247779786687135744","rt":["DignitasIntl"],"citation_ids":[910934],"posted_on":"2012-09-17T19:31:19+00:00","author":{"name":"Janine McCready","image":"https:\/\/pbs.twimg.com\/profile_images\/666440697864581121\/dZUhFbVX_normal.jpg","description":"Infectious Diseases doc. Trying to make the world a better place by preventing and *appropriately* treating one infection at a time.","id_on_source":"janinemccready","tweeter_id":"525733081","geo":{"lt":43.70011,"ln":-79.4163,"country":"CA"},"followers":724},"tweet_id":"247779786687135744"},{"url":"http:\/\/twitter.com\/#!\/AntonTankovich\/status\/247770874533523456","rt":["DignitasIntl"],"citation_ids":[910934],"posted_on":"2012-09-17T18:55:54+00:00","author":{"name":"Anton Mwewa","url":"http:\/\/anton101.deviantart.com\/","image":"http:\/\/a0.twimg.com\/profile_images\/2465277458\/image_normal.jpg","description":"Journalism grad & advertising student who doesn't know how to have fun.","id_on_source":"AntonTankovich","tweeter_id":"83822324","geo":{"lt":43.64856,"ln":-79.385324,"country":"CA"},"followers":201},"tweet_id":"247770874533523456"}],"news":[{"title":"AIDS Virus Could Be Harnessed to Fight Cancer","url":"http:\/\/www.popsci.com\/science\/article\/2012-08\/aids-virus%E2%80%99-mutant-powers-could-be-harnessed-fight-cancer","license":"public","citation_ids":[910934],"posted_on":"2012-08-28T18:23:00+00:00","summary":"Viruses are skillful mutants, changing their structures or outer proteins to evade the shifting natural defenses of their targets. (This is why you have to get a flu shot every year.) Now researchers in France report using one of the most proficient mutant","author":{"name":"Popular Science","url":"http:\/\/www.popsci.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/083\/normal\/popular_science.png?1369846957"}},{"title":"Da una proteina \"mutante\" dell'Hiv una speranza per battere i tumori","url":"http:\/\/www.repubblica.it\/salute\/ricerca\/2012\/09\/17\/news\/cancro_dal_virus_dell_hiv_una_proteina_per_sconfiggere_la_malattia-41768917\/","license":"public","citation_ids":[910934],"posted_on":"2012-09-16T22:10:00+00:00","summary":"","author":{"name":"La Repubblica","url":"http:\/\/www.repubblica.it\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/172\/normal\/image.png?1369926718"}}],"blogs":[{"title":"Using HIV to Fight Cancer","url":"http:\/\/www.united-academics.org\/magazine\/25894\/using-hiv-to-fight-cancer\/","citation_ids":[910934],"posted_on":"2012-09-02T13:00:00+00:00","summary":"The HIV virus is tricky. It uses the machinery in human cells to reproduce and mutates so fast that neither our immune system nor antiviral drugs can get a good hold on it. But, so some scientist thought, what if we can use these characteristics to our adv","author":{"name":"United Academics","url":"http:\/\/blog.united-academics.org","description":"Connect Science & Society"}}],"linkedin":[{"title":"Enlisting the AIDS virus to fight cancer [ Press Release - CNRS 24 Aug 2012]","url":"http:\/\/www.linkedin.com\/groupItem?view=&gid=3941428&item=154691388&type=member&trk=api*a215890*s223879*","citation_ids":[910934],"posted_on":"2012-08-28T15:30:36+00:00","summary":"Can HIV be transformed into a biotechnological tool for improving human health? According to a CNRS team at the Architecture et R\u00e9activit\u00e9 de l'ARN (RNA Architecture and Reactivity) laboratory, the answer is yes. \n\nTaking advantage of the HIV replication m","author":{"group_name":"Virology","group_logo":"http:\/\/m3.licdn.com\/mpr\/mpr\/p\/3\/000\/0c3\/0b9\/06873ea.png","group_description":"This group aims to bring together scientists studying in the field of Virology. Mainly for networking purposes such as finding partners for co-application on grants, conference participation, peer-review, or just discussing the latest virus outbreak, even troubleshooting various virological assays."}}]}}